Martha Jefferson Hospital is a Sentara Healthcare-owned nonprofit community hospital in Charlottesville, Virginia. It was founded in 1903 by eight local physicians. The 176-bed hospital has an employed staff of 1,600 and has 365 affiliated physicians.

During the past decade, Martha Jefferson Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 16 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Martha Jefferson Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 27 trials, followed by "Radiation Therapy Oncology Group" with 18 trials sponsored, "National Cancer Institute (NCI)" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Martha Jefferson Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "Canadian Cancer Trials Group" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Martha Jefferson Hospital" are "Lung Cancer" (10 trials), "Prostate Cancer" (7 trials), "Breast Cancer" (6 trials), "Colorectal Cancer" (5 trials) and "Head and Neck Cancer" (4 trials). Many other conditions were trialed in "Martha Jefferson Hospital" in a lesser frequency.

Most popular intervention types in "Martha Jefferson Hospital" are "Drug" (57 trials), "Other" (24 trials), "Radiation" (22 trials), "Biological" (16 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "radiation therapy" (14 trials), "Paclitaxel" (7 trials), "cisplatin" (6 trials) and "gemcitabine hydrochloride" (6 trials). Other intervention names were less common.

The vast majority of trials in "Martha Jefferson Hospital" are 54 trials for "All" genders, 10 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Martha Jefferson Hospital". undefined are not yet recruiting, 4 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Martha Jefferson Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Martha Jefferson Hospital, 5 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".